+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diverticulitis Drug"

Diverticulitis - Pipeline Insight, 2024 - Product Thumbnail Image

Diverticulitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Diverticulitis is a condition in which small pouches form in the lining of the digestive tract, usually in the large intestine. These pouches can become inflamed or infected, leading to a condition known as diverticulitis. Infectious Diseases Drugs are used to treat this condition, as well as other infections of the digestive tract. These drugs work by killing the bacteria that cause the infection, reducing inflammation, and helping the body to heal. Commonly used drugs for diverticulitis include antibiotics, antifungals, and probiotics. The Diverticulitis Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of a variety of drugs used to treat diverticulitis, as well as other infections of the digestive tract. These drugs are used to reduce inflammation, kill bacteria, and help the body to heal. Some companies in the Diverticulitis Drug market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more